Lexicon Pharmaceuticals Ownership | Who Owns Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals Ownership Summary
Lexicon Pharmaceuticals is owned by 79.84% institutional investors, 1.15% insiders, and 19.01% retail investors. Artal group is the largest institutional shareholder, holding 71.36% of LXRX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.73% of its assets in Lexicon Pharmaceuticals shares.
LXRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lexicon Pharmaceuticals | 79.84% | 1.15% | 19.01% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Artal group | 175.10M | 71.36% | $294.17M |
| Fmr | 38.69M | 15.77% | $64.99M |
| Blackrock | 9.89M | 4.03% | $16.62M |
| Braidwell lp | 8.29M | 3.38% | $13.94M |
| Vanguard group | 7.68M | 3.13% | $12.89M |
| Orbimed advisors | 5.85M | 2.38% | $9.82M |
| Point72 asset management | 4.12M | 1.68% | $6.92M |
| Geode capital management | 3.25M | 1.32% | $5.46M |
| Nea management company | 2.38M | 0.97% | $4.00M |
| State street | 2.31M | 0.94% | $3.89M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Artal group | 175.10M | 7.50% | $294.17M |
| Braidwell lp | 8.29M | 0.44% | $13.94M |
| Nea management company | 2.38M | 0.30% | $4.00M |
| Nantahala capital management | 2.30M | 0.23% | $3.87M |
| Orbimed advisors | 5.85M | 0.20% | $9.82M |
| Virtus etf advisers | 179.97K | 0.15% | $302.35K |
| Pinnacle associates | 1.72M | 0.05% | $2.88M |
| Bbr partners | 270.00K | 0.04% | $453.60K |
| Prosperity financial group | 31.50K | 0.03% | $52.92K |
| Cvi | 20.00K | 0.03% | $33.60K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Artal group | 175.10M | 7.50% | 57.55M |
| Fmr | 38.69M | 0.00% | 24.79M |
| Braidwell lp | 8.29M | 0.44% | 8.29M |
| Point72 asset management | 4.12M | 0.02% | 3.54M |
| Nantahala capital management | 2.30M | 0.23% | 2.30M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Opaleye management | - | - | -1.88M |
| Bvf inc/il | - | - | -1.69M |
| Cubist systematic strategies | - | - | -1.40M |
| Schonfeld strategic advisors | 571.49K | 0.02% | -388.66K |
| Exoduspoint capital management, lp | - | - | -319.06K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Braidwell lp | 8.29M | 0.44% | 8.29M | $13.94M |
| Nantahala capital management | 2.30M | 0.23% | 2.30M | $3.87M |
| Corebridge financial | 61.77K | 0.00% | 61.77K | $103.77K |
| Mirae asset global etfs | 47.18K | 0.00% | 47.18K | $79.27K |
| Cvi | 20.00K | 0.03% | 20.00K | $33.60K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -21.00 |
| Rothschild investment | -75.00 |
| Nisa investment advisors | -147.00 |
| Ifp advisors | -150.00 |
| Optiver b.v. | -155.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 138 | 6.15% | 288,617,050 | 3.46% | 79 | 0.62% | 70 | -2.78% | 21 | -8.70% |
| Jun 30, 2024 | 130 | 6.56% | 278,967,822 | 61.45% | 113 | 1.86% | 72 | 9.09% | 23 | -20.69% |
| Mar 31, 2024 | 122 | 10.91% | 172,789,084 | -5.49% | 78 | 1.40% | 66 | 17.86% | 29 | 26.09% |
| Dec 31, 2023 | 110 | -3.51% | 182,824,838 | -3.14% | 74 | 0.88% | 56 | 1.82% | 23 | -20.69% |
| Sep 30, 2023 | 114 | -10.24% | 188,754,252 | -1.34% | 92 | 0.90% | 55 | -31.25% | 29 | 31.82% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 24.33M | 6.73% | 52.70K |
| Fidelity Growth Compy Commingled Pl O | 20.40M | 5.64% | 2.23M |
| Fidelity Growth Company Fund | 17.24M | 4.77% | -7.87K |
| Fidelity Growth Company K6 | 5.62M | 1.56% | 54.05K |
| Vanguard Total Stock Mkt Idx Inv | 5.15M | 1.42% | - |
| Fidelity Series Growth Company | 4.55M | 1.26% | -36.74K |
| Biotech Growth Ord | 4.28M | 1.18% | - |
| iShares Russell 2000 ETF | 3.10M | 0.86% | -11.90K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.90M | 0.80% | - |
| Columbia Small Cap Value I A | 1.91M | 0.53% | 497.77K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q4 | 5 | - |
LXRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools